Protocol Feasibility and Early-Termination Risk Scoring
Forecasts protocol risk before launch so teams can reduce avoidable trial failures Evidence basis: A Scientific Reports analysis of 420k+ trials showed interpretable ML can estimate early termination risk from design features; a separate 2000+ trial operations study showed recruitment and duration efficiency can be predicted from protocol characteristics
The Problem
“Predict protocol feasibility and early-termination risk before trial launch”
Organizations face these key challenges:
Protocol feasibility assessments rely heavily on subjective expert judgment
Recruitment success and study duration are difficult to estimate accurately before launch
Termination risk is often recognized too late, after significant spend and delay
Historical trial data is fragmented across registries, internal systems, and documents
Protocol text and eligibility criteria are complex and hard to compare manually
Teams lack interpretable, feature-level explanations for why a design is risky
Country, site, and patient segment selection decisions are often weakly data-driven
Operational planning cycles are slowed by manual benchmarking and review
Impact When Solved
The Shift
Human Does
- •Review protocol design manually against feasibility and risk criteria
- •Coordinate inputs across stakeholders using spreadsheets and email
- •Assess early-termination risk based on past experience and retrospective checks
- •Document findings, recommendations, and follow-up actions in static reports
Automation
- •No AI-driven analysis is used in the legacy workflow
- •No automated prioritization of protocol risk or opportunity is available
- •No continuous monitoring or standardized risk scoring is performed
Human Does
- •Confirm final feasibility and early-termination risk decisions before protocol launch
- •Review flagged risks and approve mitigation actions or protocol changes
- •Handle exceptions, missing context, and cases that require expert judgment
AI Handles
- •Score protocol feasibility and early-termination risk from protocol characteristics
- •Prioritize high-risk design elements and surface likely operational issues early
- •Generate consistent risk summaries and recommended follow-up areas for review
- •Track scoring outputs across reviews to support standardized reporting and triage
Operating Intelligence
How Protocol Feasibility and Early-Termination Risk Scoring runs once it is live
AI runs the first three steps autonomously.
Humans own every decision.
The system gets smarter each cycle.
Who is in control at each step
Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.
Step 1
Assemble Context
Step 2
Analyze
Step 3
Recommend
Step 4
Human Decision
Step 5
Execute
Step 6
Feedback
AI lead
Autonomous execution
Human lead
Approval, override, feedback
AI handles assembly, analysis, and execution. The human gate sits at the decision point. Every cycle refines future recommendations.
The Loop
6 steps
Assemble Context
Combine the relevant records, signals, and constraints.
Analyze
Evaluate options, risk, and likely outcomes.
Recommend
Present a ranked recommendation with supporting rationale.
Human Decision
A human accepts, edits, or rejects the recommendation.
Authority gates · 1
The system must not approve a protocol for launch or make the final feasibility decision without review by clinical operations or study design leadership [S2][S3].
Why this step is human
The decision carries real-world consequences that require professional judgment and accountability.
Execute
Carry out the approved action in the operating workflow.
Feedback
Outcome data improves future recommendations.
1 operating angles mapped
Operational Depth
Technologies
Technologies commonly used in Protocol Feasibility and Early-Termination Risk Scoring implementations:
Key Players
Companies actively working on Protocol Feasibility and Early-Termination Risk Scoring solutions:
+3 more companies(sign up to see all)Real-World Use Cases
Explainable AI forecasting for protocol-specific trial timelines
Instead of guessing timelines from old averages, teams use AI with traceable evidence to forecast dates based on the exact protocol, sites, and patient realities of the planned study.
KOL and expert discovery for clinical planning via Expert Finder
A built-in tool helps teams find important medical experts and opinion leaders relevant to their trial planning work.
Snapshot-based database restoration for offline clinical trial analytics
Users can download a ready-made copy of the clinical trials database and restore it locally instead of building it from scratch.
Clinical trial operational efficiency prediction for study design planning
An ML system estimates how efficiently a planned clinical trial will recruit patients and how long it may take, based on the trial’s design choices.
Recruitment success prediction by country, disease, patient segment, and site
It estimates where and with whom a trial is most likely to enroll patients successfully, so teams can choose better locations and partners.